Ryan M. Marks

949 total citations · 1 hit paper
8 papers, 628 citations indexed

About

Ryan M. Marks is a scholar working on Molecular Biology, Reproductive Medicine and Obstetrics and Gynecology. According to data from OpenAlex, Ryan M. Marks has authored 8 papers receiving a total of 628 indexed citations (citations by other indexed papers that have themselves been cited), including 4 papers in Molecular Biology, 4 papers in Reproductive Medicine and 3 papers in Obstetrics and Gynecology. Recurrent topics in Ryan M. Marks's work include Endometriosis Research and Treatment (4 papers), CRISPR and Genetic Engineering (4 papers) and Uterine Myomas and Treatments (3 papers). Ryan M. Marks is often cited by papers focused on Endometriosis Research and Treatment (4 papers), CRISPR and Genetic Engineering (4 papers) and Uterine Myomas and Treatments (3 papers). Ryan M. Marks collaborates with scholars based in Canada, United States and Sweden. Ryan M. Marks's co-authors include Chandrakant Tayade, Madhuri Koti, Jessica E. Miller, Lindsey K. Symons, Kiera Liblik, Vanessa R. Kay, Stephany P. Monsanto, Soo Hyun Ahn, Asgerally T. Fazleabas and Ronald D. Cohn and has published in prestigious journals such as Nature, SHILAP Revista de lepidopterología and The FASEB Journal.

In The Last Decade

Ryan M. Marks

8 papers receiving 620 citations

Hit Papers

The Immunopathophysiology of Endometriosis 2018 2026 2020 2023 2018 100 200 300

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Ryan M. Marks Canada 7 446 371 327 142 47 8 628
Shigetatsu Shiokawa Japan 13 140 0.3× 217 0.6× 123 0.4× 120 0.8× 102 2.2× 18 468
Jennifer Hardt United States 6 236 0.5× 188 0.5× 163 0.5× 129 0.9× 45 1.0× 7 407
Esther García France 4 196 0.4× 231 0.6× 78 0.2× 83 0.6× 50 1.1× 4 428
Kelsey E. Quinn United States 10 54 0.1× 174 0.5× 98 0.3× 207 1.5× 34 0.7× 20 444
Peter T Ruane United Kingdom 12 182 0.4× 295 0.8× 162 0.5× 151 1.1× 127 2.7× 22 504
Maria Rosa Guglielmino Italy 8 164 0.4× 229 0.6× 94 0.3× 318 2.2× 176 3.7× 8 545
Haruko Fujii Japan 11 137 0.3× 50 0.1× 113 0.3× 89 0.6× 24 0.5× 19 368
M A Boric Chile 9 240 0.5× 175 0.5× 137 0.4× 55 0.4× 46 1.0× 11 328
M. Zahied Johan Australia 8 96 0.2× 92 0.2× 81 0.2× 92 0.6× 8 0.2× 9 246

Countries citing papers authored by Ryan M. Marks

Since Specialization
Citations

This map shows the geographic impact of Ryan M. Marks's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ryan M. Marks with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ryan M. Marks more than expected).

Fields of papers citing papers by Ryan M. Marks

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ryan M. Marks. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ryan M. Marks. The network helps show where Ryan M. Marks may publish in the future.

Co-authorship network of co-authors of Ryan M. Marks

This figure shows the co-authorship network connecting the top 25 collaborators of Ryan M. Marks. A scholar is included among the top collaborators of Ryan M. Marks based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ryan M. Marks. Ryan M. Marks is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

8 of 8 papers shown
1.
Marks, Ryan M., et al.. (2023). Advances in CRISPR/Cas9 Genome Editing for the Treatment of Muscular Dystrophies. Human Gene Therapy. 34(9-10). 388–403. 14 indexed citations
2.
Ahmed, Abdalla, Grace Meijuan Yang, Elzbieta Hyatt, et al.. (2023). Prevention of early-onset cardiomyopathy in Dmd exon 52–54 deletion mice by CRISPR-Cas9-mediated exon skipping. Molecular Therapy — Methods & Clinical Development. 30. 246–258. 6 indexed citations
3.
Teng, Allen C. T., Suja Shrestha, Ryan M. Marks, et al.. (2022). An efficient and cost-effective purification protocol for Staphylococcus aureus Cas9 nuclease. STAR Protocols. 4(1). 101933–101933. 2 indexed citations
4.
Lingegowda, Harshavardhan, Jessica E. Miller, Ryan M. Marks, et al.. (2021). Synthetic Cannabinoid Agonist WIN 55212-2 Targets Proliferation, Angiogenesis, and Apoptosis via MAPK/AKT Signaling in Human Endometriotic Cell Lines and a Murine Model of Endometriosis. SHILAP Revista de lepidopterología. 3. 726936–726936. 7 indexed citations
5.
Miller, Jessica E., Soo Hyun Ahn, Ryan M. Marks, et al.. (2020). IL-17A Modulates Peritoneal Macrophage Recruitment and M2 Polarization in Endometriosis. Frontiers in Immunology. 11. 108–108. 94 indexed citations
6.
Kemaladewi, Dwi U., Steven Erwood, Kinga I. Gawlik, et al.. (2019). A mutation-independent approach for muscular dystrophy via upregulation of a modifier gene. Nature. 572(7767). 125–130. 100 indexed citations
7.
Symons, Lindsey K., Jessica E. Miller, Kathrin Tyryshkin, et al.. (2019). Neutrophil recruitment and function in endometriosis patients and a syngeneic murine model. The FASEB Journal. 34(1). 1558–1575. 50 indexed citations
8.
Symons, Lindsey K., Jessica E. Miller, Vanessa R. Kay, et al.. (2018). The Immunopathophysiology of Endometriosis. Trends in Molecular Medicine. 24(9). 748–762. 355 indexed citations breakdown →

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026